{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T04:50:24Z","timestamp":1791607824754,"version":"4.3.4"},"reference-count":138,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Nanomedicine: Nanotechnology, Biology and Medicine"],"published-print":{"date-parts":[[2025,8]]},"DOI":"10.1016\/j.nano.2025.102845","type":"journal-article","created":{"date-parts":[[2025,7,15]],"date-time":"2025-07-15T19:27:08Z","timestamp":1752607628000},"page":"102845","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Advanced ocular drug delivery in microgravity: Nanotherapeutic applications as cardiovascular and ophthalmic countermeasures"],"prefix":"10.1016","volume":"68","author":[{"given":"Ryung","family":"Lee","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joshua","family":"Ong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ethan","family":"Waisberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rahul","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alex","family":"Ngo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas H.","family":"Mader","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Berdahl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Umesh C.","family":"Karandikar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandro","family":"Grattoni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew G.","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.nano.2025.102845_bb0005","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41526-020-00124-6","article-title":"Red risks for a journey to the red planet: the highest priority human health risks for a mission to Mars","volume":"6","author":"Patel","year":"2020","journal-title":"NPJ Microgravity"},{"key":"10.1016\/j.nano.2025.102845_bb0010","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1038\/s41578-024-00691-0","article-title":"Advanced material technologies for space and terrestrial medicine","volume":"9","author":"Chua","year":"2024","journal-title":"Nat Rev Mater"},{"key":"10.1016\/j.nano.2025.102845_bb0015","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41526-023-00335-7","article-title":"Ocular complaints and diagnoses in spaceflight","volume":"10","author":"Meer","year":"2024","journal-title":"NPJ Microgravity"},{"key":"10.1016\/j.nano.2025.102845_bb0020","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1667\/RR1580.1","article-title":"NASA Study of Cataract in Astronauts (NASCA). Report 1: cross-sectional study of the relationship of exposure to space radiation and risk of lens opacity","volume":"172","author":"Chylack","year":"2009","journal-title":"Radiat Res"},{"key":"10.1016\/j.nano.2025.102845_bb0025","article-title":"Spaceflight associated neuro-ocular syndrome (SANS) and the neuro-ophthalmologic effects of microgravity: a review and an update","volume":"6","author":"Lee","year":"2020","journal-title":"NPJ Microgravity"},{"key":"10.1016\/j.nano.2025.102845_bb0030","doi-asserted-by":"crossref","first-page":"629","DOI":"10.3357\/ASEM.2314.2008","article-title":"Human health and performance for long-duration spaceflight","volume":"79","author":"Baisden","year":"2008","journal-title":"Aviat Space Environ Med"},{"key":"10.1016\/j.nano.2025.102845_bb0035","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.pcad.2023.07.009","article-title":"Cardiovascular disease in space: a systematic review","volume":"81","author":"Krittanawong","year":"2023","journal-title":"Prog Cardiovasc Dis"},{"key":"10.1016\/j.nano.2025.102845_bb0040","doi-asserted-by":"crossref","first-page":"2058","DOI":"10.1016\/j.ophtha.2011.06.021","article-title":"Optic disc edema, globe flattening, choroidal folds, and hyperopic shifts observed in astronauts after long-duration space flight","volume":"118","author":"Mader","year":"2011","journal-title":"Ophthalmology"},{"key":"10.1016\/j.nano.2025.102845_bb0045","series-title":"Medical Kit - Contents and Reference","author":"NASA","year":"2015"},{"key":"10.1016\/j.nano.2025.102845_bb0050","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1038\/gt.2012.56","article-title":"A nanomedicine to treat ocular surface inflammation: performance on an experimental dry eye murine model","volume":"20","author":"Contreras-Ruiz","year":"2013","journal-title":"Gene Ther"},{"key":"10.1016\/j.nano.2025.102845_bb0055","article-title":"Spaceflight associated dry eye syndrome (SADES): radiation, stressors, and ocular surface health","author":"Lee","year":"2024","journal-title":"Life Sci Space Res"},{"key":"10.1016\/j.nano.2025.102845_bb0060","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1097\/OPX.0000000000001387","article-title":"Impact of dry eye on visual acuity and contrast sensitivity: dry eye assessment and management study","volume":"96","author":"Szczotka-Flynn","year":"2019","journal-title":"Optom Vis Sci"},{"key":"10.1016\/j.nano.2025.102845_bb0065","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/S0002-9394(01)01365-4","article-title":"Impaired functional visual acuity of dry eye patients","volume":"133","author":"Goto","year":"2002","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.nano.2025.102845_bb0070","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.jtos.2016.09.003","article-title":"New perspectives on dry eye definition and diagnosis: a consensus report by the Asia Dry Eye Society","volume":"15","author":"Tsubota","year":"2017","journal-title":"Ocul Surf"},{"key":"10.1016\/j.nano.2025.102845_bb0075","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.jtos.2015.07.003","article-title":"Accelerated restoration of ocular surface health in dry eye disease by self-retained cryopreserved amniotic membrane","volume":"14","author":"Cheng","year":"2016","journal-title":"Ocul Surf"},{"issue":"46","key":"10.1016\/j.nano.2025.102845_bb0080","first-page":"169","article-title":"The ocular surface during spaceflight: post-mission symptom report, extraterrestrial risks, and in-flight therapeutics","author":"Ong","year":"2025","journal-title":"Life Sci Space Res"},{"key":"10.1016\/j.nano.2025.102845_bb0085","article-title":"Biophysics of ophthalmic medications during spaceflight: principles of ocular fluid dynamics and pharmacokinetics in microgravity","author":"Memon","year":"2024","journal-title":"Life Sci Space Res"},{"key":"10.1016\/j.nano.2025.102845_bb0090","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.ajo.2022.02.010","article-title":"Evaluation of Meibum lipid composition according to tear interferometric patterns: RRH: Meibum composition according to interferometric patterns","volume":"240","author":"Jun","year":"2022","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.nano.2025.102845_bb0095","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1096\/fasebj.13.9.1031","article-title":"Space travel directly induces skeletal muscle atrophy","volume":"13","author":"Vandenburgh","year":"1999","journal-title":"FASEB J"},{"key":"10.1016\/j.nano.2025.102845_bb0100","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1016\/j.actaastro.2022.10.037","article-title":"Capillary driven fluid flows in microgravity","volume":"204","author":"Smirnova","year":"2023","journal-title":"Acta Astronaut"},{"key":"10.1016\/j.nano.2025.102845_bb0105","series-title":"Fluids, Materials and Microgravity","isbn-type":"print","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/B978-008044508-3\/50003-7","article-title":"Chapter 2 - fundamental concepts, mathematical models and scaling analysis for the microgravity environment","author":"Lappa","year":"2004","ISBN":"https:\/\/id.crossref.org\/isbn\/9780080445083"},{"key":"10.1016\/j.nano.2025.102845_bb0110","doi-asserted-by":"crossref","DOI":"10.3389\/fphys.2023.1281327","article-title":"Dry eye disease in astronauts: a narrative review","volume":"14","author":"Ax","year":"2023","journal-title":"Front Physiol"},{"key":"10.1016\/j.nano.2025.102845_bb0115","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1007\/s13346-016-0339-2","article-title":"A comprehensive insight on ocular pharmacokinetics","volume":"6","author":"Agrahari","year":"2016","journal-title":"Drug Deliv Transl Res"},{"issue":"168","key":"10.1016\/j.nano.2025.102845_bb0120","article-title":"Impact of mucin on drug diffusion: development of a straightforward in vitro method for the determination of drug diffusivity in the presence of mucin","volume":"12","author":"Falavigna","year":"2020","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.nano.2025.102845_bb0125","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1097\/01.ico.0000154235.64359.d3","article-title":"Radiotherapy-induced ocular surface disease","volume":"24","author":"Barabino","year":"2005","journal-title":"Cornea"},{"key":"10.1016\/j.nano.2025.102845_bb0130","doi-asserted-by":"crossref","DOI":"10.1029\/2021SW002749","article-title":"Beating 1 sievert: optimal radiation shielding of astronauts on a mission to Mars","volume":"19","author":"Dobynde","year":"2021","journal-title":"Space Weather"},{"key":"10.1016\/j.nano.2025.102845_bb0135","doi-asserted-by":"crossref","first-page":"491","DOI":"10.3390\/life4030491","article-title":"Space radiation: the number one risk to astronaut health beyond low Earth orbit","volume":"4","author":"Chancellor","year":"2014","journal-title":"Life"},{"key":"10.1016\/j.nano.2025.102845_bb0140","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.icrp.2007.10.003","article-title":"Preface, executive summary and glossary","volume":"37","year":"2007","journal-title":"Ann ICRP"},{"key":"10.1016\/j.nano.2025.102845_bb0145","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1016\/0094-5765(94)90170-8","article-title":"HZE particle effects in space","volume":"32","author":"Horneck","year":"1994","journal-title":"Acta Astronaut"},{"key":"10.1016\/j.nano.2025.102845_bb0150","doi-asserted-by":"crossref","first-page":"2129","DOI":"10.1118\/1.3693052","article-title":"Organ doses for reference pediatric and adolescent patients undergoing computed tomography estimated by Monte Carlo simulation","volume":"39","author":"Lee","year":"2012","journal-title":"Med Phys"},{"key":"10.1016\/j.nano.2025.102845_bb0155","doi-asserted-by":"crossref","DOI":"10.1126\/science.aau8650","article-title":"The NASA twins study: a multidimensional analysis of a year-long human spaceflight","volume":"364","author":"Garrett-Bakelman","year":"2019","journal-title":"Science"},{"key":"10.1016\/j.nano.2025.102845_bb0160","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.1016\/j.cell.2020.10.050","article-title":"Fundamental biological features of spaceflight: advancing the field to enable deep-space exploration","volume":"183","author":"Afshinnekoo","year":"2020","journal-title":"Cell"},{"key":"10.1016\/j.nano.2025.102845_bb0165","doi-asserted-by":"crossref","DOI":"10.1167\/iovs.17-23402","article-title":"Potential role of oxidative stress in ocular surface inflammation and dry eye disease","volume":"59","author":"Dogru","year":"2018","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.nano.2025.102845_bb0170","doi-asserted-by":"crossref","first-page":"637","DOI":"10.2147\/CIA.S52662","article-title":"Oxidative stress and its downstream signaling in aging eyes","volume":"9","author":"Pinazo-Dur\u00e1n","year":"2014","journal-title":"Clin Interv Aging"},{"key":"10.1016\/j.nano.2025.102845_bb0175","doi-asserted-by":"crossref","first-page":"1799","DOI":"10.1038\/s41433-024-03005-4","article-title":"Ocular immunology and inflammation under microgravity conditions and the pathogenesis of spaceflight associated neuro-ocular syndrome (SANS)","volume":"38","author":"Masalkhi","year":"2024","journal-title":"Eye"},{"key":"10.1016\/j.nano.2025.102845_bb0180","doi-asserted-by":"crossref","first-page":"4417","DOI":"10.1096\/fj.14-264838","article-title":"Medication use by U.S. crewmembers on the International Space Station","volume":"29","author":"Wotring","year":"2015","journal-title":"FASEB J"},{"key":"10.1016\/j.nano.2025.102845_bb0185","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1056\/NEJMoa1209825","article-title":"Risk of ischemic heart disease in women after radiotherapy for breast cancer","volume":"368","author":"Darby","year":"2013","journal-title":"N Engl J Med"},{"key":"10.1016\/j.nano.2025.102845_bb0190","doi-asserted-by":"crossref","first-page":"1484","DOI":"10.1016\/j.ijrobp.2007.05.034","article-title":"Cardiac exposures in breast cancer radiotherapy: 1950s\u20131990s","volume":"69","author":"Taylor","year":"2007","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.nano.2025.102845_bb0195","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.117.005564","article-title":"Incidence rate of cardiovascular disease end points in the National Aeronautics and Space Administration astronaut corps","volume":"6","author":"Ade","year":"2017","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.nano.2025.102845_bb0200","doi-asserted-by":"crossref","DOI":"10.1038\/srep29901","article-title":"Apollo lunar astronauts show higher cardiovascular disease mortality: possible deep space radiation effects on the vascular endothelium","volume":"6","author":"Delp","year":"2016","journal-title":"Sci Rep"},{"key":"10.1016\/j.nano.2025.102845_bb0205","doi-asserted-by":"crossref","first-page":"2538","DOI":"10.1111\/bph.15822","article-title":"Physiological adaptations affecting drug pharmacokinetics in space: what do we really know? A critical review of the literature","volume":"179","author":"Dello Russo","year":"2022","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.nano.2025.102845_bb0210","doi-asserted-by":"crossref","first-page":"281","DOI":"10.4103\/ijp.ijp_591_23","article-title":"Space medicine: hunting for pharmacologist\u2019s guide in dealing with drugs in microgravity","volume":"55","author":"Mahalmani","year":"2023","journal-title":"Indian J Pharm"},{"key":"10.1016\/j.nano.2025.102845_bb0215","doi-asserted-by":"crossref","DOI":"10.1152\/jappl.1996.81.1.105","article-title":"Regulation of body fluid compartments during short-term spaceflight","author":"Leach","year":"1996","journal-title":"J Appl Physiol"},{"key":"10.1016\/j.nano.2025.102845_bb0220","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2165\/11318140-000000000-00000","article-title":"Augmented renal clearance","volume":"49","author":"Udy","year":"2010","journal-title":"Clin Pharmacokinet"},{"key":"10.1016\/j.nano.2025.102845_bb0225","first-page":"748","article-title":"Study of minimal inhibitory concentration of antibiotics on bacteria cultivated in vitro in space (Cytos 2 Experiment)","volume":"56","author":"Tixador","year":"1985","journal-title":"Aviat Space Environ Med"},{"key":"10.1016\/j.nano.2025.102845_bb0230","first-page":"1683","article-title":"Simulated microgravity-induced changes to drug response in cancer cells quantified using fluorescence morphometry","volume":"13","author":"McKinley","year":"2023","journal-title":"Life (Basel)"},{"key":"10.1016\/j.nano.2025.102845_bb0235","doi-asserted-by":"crossref","first-page":"8","DOI":"10.3357\/ASEM.3153.2012","article-title":"Gender differences in pharmacokinetics of antipyrine in a simulated weightlessness rat model","volume":"83","author":"Wei","year":"2012","journal-title":"Aviat Space Environ Med"},{"key":"10.1016\/j.nano.2025.102845_bb0240","doi-asserted-by":"crossref","first-page":"2374","DOI":"10.1152\/jappl.2001.91.5.2374","article-title":"Invited review: gender issues related to spaceflight: a NASA perspective","volume":"91","author":"Harm","year":"2001","journal-title":"J Appl Physiol"},{"key":"10.1016\/j.nano.2025.102845_bb0245","doi-asserted-by":"crossref","first-page":"S2","DOI":"10.1016\/j.ejps.2017.05.025","article-title":"Drugs in space: pharmacokinetics and pharmacodynamics in astronauts","volume":"109","author":"Kast","year":"2017","journal-title":"Eur J Pharm Sci"},{"key":"10.1016\/j.nano.2025.102845_bb0250","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1046\/j.1440-1681.2000.03288.x","article-title":"Biopharmaceutical considerations in topical ocular drug delivery","volume":"27","author":"Davies","year":"2000","journal-title":"Clin Exp Pharmacol Physiol"},{"key":"10.1016\/j.nano.2025.102845_bb0255","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1136\/bjo.57.5.339","article-title":"Corneal and conjunctival calcification in chronic renal failure","volume":"57","author":"Porter","year":"1973","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.nano.2025.102845_bb0260","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1021\/js9802594","article-title":"Permeability of cornea, sclera, and conjunctiva: a literature analysis for drug delivery to the eye","volume":"87","author":"Prausnitz","year":"1998","journal-title":"J Pharm Sci"},{"key":"10.1016\/j.nano.2025.102845_bb0265","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41526-024-00414-3","article-title":"Expiration analysis of the international Space Station formulary for exploration mission planning","volume":"10","author":"Diaz","year":"2024","journal-title":"NPJ Microgravity"},{"key":"10.1016\/j.nano.2025.102845_bb0270","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1038\/s41526-019-0075-2","article-title":"Supplying a pharmacy for NASA exploration spaceflight: challenges and current understanding","volume":"5","author":"Blue","year":"2019","journal-title":"NPJ Microgravity"},{"key":"10.1016\/j.nano.2025.102845_bb0275","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1038\/s41526-023-00271-6","article-title":"The effect of long-term spaceflight on drug potency and the risk of medication failure","volume":"9","author":"Reichard","year":"2023","journal-title":"NPJ Microgravity"},{"key":"10.1016\/j.nano.2025.102845_bb0280","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1038\/s41526-019-0076-1","article-title":"Limitations in predicting radiation-induced pharmaceutical instability during long-duration spaceflight","volume":"5","author":"Blue","year":"2019","journal-title":"NPJ Microgravity"},{"key":"10.1016\/j.nano.2025.102845_bb0285","series-title":"Evidence Report: Risk of Ineffective or Toxic Medication During Long-duration Exploration Spaceflight","author":"Reichard","year":"2023"},{"key":"10.1016\/j.nano.2025.102845_bb0290","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1186\/s40168-022-01332-w","article-title":"Machine learning algorithm to characterize antimicrobial resistance associated with the International Space Station surface microbiome","volume":"10","author":"Madrigal","year":"2022","journal-title":"Microbiome"},{"key":"10.1016\/j.nano.2025.102845_bb0295","first-page":"29","article-title":"Combined effect of simulated microgravity and low-dose ionizing radiation on structure and antibiotic resistance of a synthetic community model of bacteria isolated from spacecraft assembly room","volume":"38","author":"Lu","year":"2023","journal-title":"Life Sci Space Res"},{"key":"10.1016\/j.nano.2025.102845_bb0300","doi-asserted-by":"crossref","DOI":"10.1016\/j.jsse.2025.04.004","article-title":"Spaceflight associated dry eye syndrome (SADES): outflow biophysics and infection risk","author":"Lee","year":"2025","journal-title":"Journal of Space Safety Engineering"},{"key":"10.1016\/j.nano.2025.102845_bb0305","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-023-42104-w","article-title":"Microbial adaptation to spaceflight is correlated with bacteriophage-encoded functions","volume":"15","author":"Irby","year":"2024","journal-title":"Nat Commun"},{"key":"10.1016\/j.nano.2025.102845_bb0310","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1186\/s40168-019-0666-x","article-title":"Characterization of the total and viable bacterial and fungal communities associated with the International Space Station surfaces","volume":"7","author":"Checinska Sielaff","year":"2019","journal-title":"Microbiome"},{"key":"10.1016\/j.nano.2025.102845_bb0315","doi-asserted-by":"crossref","DOI":"10.1016\/S2666-5247(24)00098-3","article-title":"Infections in long-duration space missions","author":"Cowen","year":"2024","journal-title":"Lancet Microbe"},{"key":"10.1016\/j.nano.2025.102845_bb0320","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.actbio.2023.01.019","article-title":"Using inorganic nanoparticles to fight fungal infections in the antimicrobial resistant era","volume":"158","author":"Huang","year":"2023","journal-title":"Acta Biomater"},{"key":"10.1016\/j.nano.2025.102845_bb0325","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/0094-5765(94)90119-8","article-title":"Effect of space flight on cytokine production","volume":"33","author":"Sonnenfeld","year":"1994","journal-title":"Acta Astronaut"},{"key":"10.1016\/j.nano.2025.102845_bb0330","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41526-024-00446-9","article-title":"Challenges for the human immune system after leaving Earth","volume":"10","author":"Marchal","year":"2024","journal-title":"npj Microgravity"},{"key":"10.1016\/j.nano.2025.102845_bb0335","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2018.01437","article-title":"Immune system dysregulation during spaceflight: potential countermeasures for deep space exploration missions","volume":"9","author":"Crucian","year":"2018","journal-title":"Front Immunol"},{"key":"10.1016\/j.nano.2025.102845_bb0340","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1093\/cid\/cis861","article-title":"Infection prevention and control during prolonged human space travel","volume":"56","author":"Mermel","year":"2013","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.nano.2025.102845_bb0345","doi-asserted-by":"crossref","first-page":"4954","DOI":"10.1038\/s41467-024-49211-2","article-title":"Single-cell multi-ome and immune profiles of the Inspiration4 crew reveal conserved, cell-type, and sex-specific responses to spaceflight","volume":"15","author":"Kim","year":"2024","journal-title":"Nat Commun"},{"key":"10.1016\/j.nano.2025.102845_bb0350","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1002\/cpt.2432","article-title":"Clinical and molecular perspectives on inflammation-mediated regulation of drug metabolism and transport","volume":"112","author":"Dunvald","year":"2022","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.nano.2025.102845_bb0355","doi-asserted-by":"crossref","DOI":"10.1016\/j.pharmthera.2020.107627","article-title":"Inflammation is a major regulator of drug metabolizing enzymes and transporters: consequences for the personalization of drug treatment","volume":"215","author":"Stanke-Labesque","year":"2020","journal-title":"Pharmacol Ther"},{"key":"10.1016\/j.nano.2025.102845_bb0360","article-title":"Ocular nanomedicine","volume":"9","author":"Tang","year":"2022","journal-title":"Adv Sci"},{"key":"10.1016\/j.nano.2025.102845_bb0365","doi-asserted-by":"crossref","first-page":"1232","DOI":"10.3390\/pharmaceutics12121232","article-title":"Biodegradable nanoparticle for cornea drug delivery: focus review","volume":"12","author":"Mobaraki","year":"2020","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.nano.2025.102845_bb0370","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1089\/jop.2012.0069","article-title":"Indomethacin-loaded solid lipid nanoparticles for ocular delivery: development, characterization, and in vitro evaluation","volume":"29","author":"Hippalgaonkar","year":"2013","journal-title":"J Ocul Pharmacol Ther"},{"key":"10.1016\/j.nano.2025.102845_bb0380","doi-asserted-by":"crossref","DOI":"10.3390\/molecules28031260","article-title":"Mesoporous silica nanoparticles coated with carboxymethyl chitosan for 5-fluorouracil ocular delivery: characterization, in vitro and in vivo studies","volume":"28","author":"Alhowyan","year":"2023","journal-title":"Molecules"},{"key":"10.1016\/j.nano.2025.102845_bb0385","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0066434","article-title":"BMP7 gene transfer via gold nanoparticles into stroma inhibits corneal fibrosis in vivo","volume":"8","author":"Tandon","year":"2013","journal-title":"PloS One"},{"key":"10.1016\/j.nano.2025.102845_bb0390","doi-asserted-by":"crossref","DOI":"10.3389\/fbioe.2020.600384","article-title":"In situ gelling amphotericin B nanofibers: a new option for the treatment of keratomycosis","volume":"8","author":"G\u00f6ttel","year":"2020","journal-title":"Front Bioeng Biotechnol"},{"key":"10.1016\/j.nano.2025.102845_bb0395","doi-asserted-by":"crossref","DOI":"10.1016\/j.carbpol.2023.120822","article-title":"Chitosan-poly(lactide-co-glycolide)\/poloxamer mixed micelles as a mucoadhesive thermo-responsive moxifloxacin eye drop to improve treatment efficacy in bacterial keratitis","volume":"312","author":"Ch","year":"2023","journal-title":"Carbohydr Polym"},{"key":"10.1016\/j.nano.2025.102845_bb0400","doi-asserted-by":"crossref","first-page":"27835","DOI":"10.1039\/D0RA04971A","article-title":"Nanocarriers for ocular drug delivery: current status and translational opportunity","volume":"10","author":"Gorantla","year":"2020","journal-title":"RSC Adv"},{"key":"10.1016\/j.nano.2025.102845_bb0405","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.actbio.2021.10.047","article-title":"Mucoadhesive phenylboronic acid conjugated chitosan oligosaccharide-vitamin E copolymer for topical ocular delivery of voriconazole: synthesis, in vitro\/vivo evaluation, and mechanism","volume":"138","author":"Sun","year":"2022","journal-title":"Acta Biomater"},{"key":"10.1016\/j.nano.2025.102845_bb0410","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1186\/s12951-022-01658-5","article-title":"Immune modulating nanoparticles for the treatment of ocular diseases","volume":"20","author":"Fang","year":"2022","journal-title":"J Nanobiotechnology"},{"key":"10.1016\/j.nano.2025.102845_bb0415","doi-asserted-by":"crossref","first-page":"1472","DOI":"10.3390\/pharmaceutics13091472","article-title":"mRNA-based nanomedicinal products to address corneal inflammation by interleukin-10 supplementation","volume":"13","author":"G\u00f3mez-Aguado","year":"2021","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.nano.2025.102845_bb0420","doi-asserted-by":"crossref","first-page":"351","DOI":"10.3390\/ph13110351","article-title":"Nanotechnology for the treatment of allergic conjunctival diseases","volume":"13","author":"Liu","year":"2020","journal-title":"Pharmaceuticals (Basel)"},{"key":"10.1016\/j.nano.2025.102845_bb0425","doi-asserted-by":"crossref","first-page":"465","DOI":"10.2217\/nnm-2018-0278","article-title":"Solid lipid nanoparticles for ocular delivery of isoniazid: evaluation, proof of concept and in vivo safety & kinetics","volume":"14","author":"Singh","year":"2019","journal-title":"Nanomedicine (Lond)"},{"key":"10.1016\/j.nano.2025.102845_bb0430","doi-asserted-by":"crossref","DOI":"10.3389\/fbioe.2023.1177151","article-title":"Advances in nanomaterial-based targeted drug delivery systems","volume":"11","author":"Cheng","year":"2023","journal-title":"Front Bioeng Biotechnol"},{"key":"10.1016\/j.nano.2025.102845_bb0435","doi-asserted-by":"crossref","DOI":"10.3390\/cells10092409","article-title":"Epidermal growth factor receptor expression in the corneal epithelium","volume":"10","author":"Peterson","year":"2021","journal-title":"Cells"},{"key":"10.1016\/j.nano.2025.102845_bb0440","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajps.2023.100847","article-title":"Contact lens as an emerging platform for ophthalmic drug delivery: a systematic review","volume":"18","author":"Yang","year":"2023","journal-title":"Asian Journal of Pharmaceutical Sciences"},{"key":"10.1016\/j.nano.2025.102845_bb0445","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.jconrel.2016.02.012","article-title":"In vitro and in vivo evaluation of novel implantation technology in hydrogel contact lenses for controlled drug delivery","volume":"226","author":"Maulvi","year":"2016","journal-title":"J Control Release"},{"key":"10.1016\/j.nano.2025.102845_bb0450","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/j.jconrel.2011.09.087","article-title":"Sustained in vivo release from imprinted therapeutic contact lenses","volume":"157","author":"Tieppo","year":"2012","journal-title":"J Control Release"},{"key":"10.1016\/j.nano.2025.102845_bb0455","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41526-023-00279-y","article-title":"Ocular conditions and injuries, detection and management in spaceflight","volume":"9","author":"Meer","year":"2023","journal-title":"NPJ Microgravity"},{"key":"10.1016\/j.nano.2025.102845_bb0460","doi-asserted-by":"crossref","first-page":"2659","DOI":"10.2147\/IDR.S463779","article-title":"A comprehensive review of microbial biofilms on contact lenses: challenges and solutions","volume":"17","author":"Voinescu","year":"2024","journal-title":"Infect Drug Resist"},{"key":"10.1016\/j.nano.2025.102845_bb0465","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/j.nantod.2015.06.006","article-title":"Nanoparticle uptake: the phagocyte problem","volume":"10","author":"Gustafson","year":"2015","journal-title":"Nano Today"},{"key":"10.1016\/j.nano.2025.102845_bb0470","doi-asserted-by":"crossref","first-page":"5552","DOI":"10.1039\/c3cs60064e","article-title":"Cytokines as biomarkers of nanoparticle immunotoxicity","volume":"42","author":"Elsabahy","year":"2013","journal-title":"Chem Soc Rev"},{"key":"10.1016\/j.nano.2025.102845_bb0475","doi-asserted-by":"crossref","DOI":"10.1016\/j.addr.2023.115044","article-title":"The interplay between PEGylated nanoparticles and blood immune system","volume":"200","author":"Guo","year":"2023","journal-title":"Adv Drug Deliv Rev"},{"key":"10.1016\/j.nano.2025.102845_bb0480","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajps.2024.100928","article-title":"Advancing ophthalmic delivery of flurbiprofen via synergistic chiral resolution and ion-pairing strategies","volume":"19","author":"Ma","year":"2024","journal-title":"Asian Journal of Pharmaceutical Sciences"},{"key":"10.1016\/j.nano.2025.102845_bb0485","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/j.ejpb.2008.03.005","article-title":"The influence of cationic lipid type on in-vitro release kinetic profiles of antisense oligonucleotide from cationic nanoemulsions","volume":"70","author":"Hagigit","year":"2008","journal-title":"Eur J Pharm Biopharm"},{"key":"10.1016\/j.nano.2025.102845_bb0490","doi-asserted-by":"crossref","first-page":"4862","DOI":"10.1021\/acs.molpharmaceut.8b00516","article-title":"Encapsulation of azithromycin ion pair in liposome for enhancing ocular delivery and therapeutic efficacy on dry eye","volume":"15","author":"Ren","year":"2018","journal-title":"Mol Pharm"},{"key":"10.1016\/j.nano.2025.102845_bb0495","doi-asserted-by":"crossref","DOI":"10.1002\/btm2.10238","article-title":"An ion-paired moxifloxacin nanosuspension eye drop provides improved prevention and treatment of ocular infection","volume":"6","author":"Josyula","year":"2021","journal-title":"Bioeng Transl Med"},{"key":"10.1016\/j.nano.2025.102845_bb0500","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.2147\/IJN.S237314","article-title":"Chitosan-coated PLGA nanoparticles for enhanced ocular anti-inflammatory efficacy of atorvastatin calcium","volume":"15","author":"Arafa","year":"2020","journal-title":"Int J Nanomedicine"},{"key":"10.1016\/j.nano.2025.102845_bb0505","doi-asserted-by":"crossref","DOI":"10.3390\/ijms231810975","article-title":"Recent advances of chitosan formulations in biomedical applications","volume":"23","author":"Abourehab","year":"2022","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.nano.2025.102845_bb0510","doi-asserted-by":"crossref","first-page":"7861","DOI":"10.2147\/IJN.S269004","article-title":"Clarithromycin-loaded ocular chitosan nanoparticle: formulation, optimization, characterization, ocular irritation, and antimicrobial activity","volume":"15","author":"Bin-Jumah","year":"2020","journal-title":"Int J Nanomedicine"},{"key":"10.1016\/j.nano.2025.102845_bb0515","doi-asserted-by":"crossref","first-page":"1590","DOI":"10.3390\/pharmaceutics13101590","article-title":"Chitosan-coated PLGA nanoparticles encapsulating triamcinolone acetonide as a potential candidate for sustained ocular drug delivery","volume":"13","author":"Dandamudi","year":"2021","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.nano.2025.102845_bb0520","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1007\/s12272-001-1266-6","article-title":"Chitosan based nanocarriers for indomethacin ocular delivery","volume":"31","author":"Badawi","year":"2008","journal-title":"Arch Pharm Res"},{"key":"10.1016\/j.nano.2025.102845_bb0525","doi-asserted-by":"crossref","first-page":"e707","DOI":"10.1002\/agt2.707","article-title":"Carbon quantum dots in biomedical applications: advances, challenges, and future prospects","volume":"6","author":"Pechnikova","year":"2025","journal-title":"Aggregate"},{"key":"10.1016\/j.nano.2025.102845_bb0530","doi-asserted-by":"crossref","DOI":"10.3389\/fchem.2023.1227843","article-title":"Progress in drug delivery and diagnostic applications of carbon dots: a systematic review","volume":"11","author":"Kaurav","year":"2023","journal-title":"Front Chem"},{"key":"10.1016\/j.nano.2025.102845_bb0535","doi-asserted-by":"crossref","first-page":"3760","DOI":"10.1021\/acsami.2c18598","article-title":"Influence of the size and charge of carbon quantum dots on their corneal penetration and permeation enhancing properties","volume":"15","author":"De Hoon","year":"2023","journal-title":"ACS Appl Mater Interfaces"},{"key":"10.1016\/j.nano.2025.102845_bb0540","doi-asserted-by":"crossref","first-page":"4045","DOI":"10.2147\/IJN.S456613","article-title":"Antioxidant carbon dots nanozyme loaded in thermosensitive in situ hydrogel system for efficient dry eye disease treatment","volume":"19","author":"Wei","year":"2024","journal-title":"Int J Nanomedicine"},{"key":"10.1016\/j.nano.2025.102845_bb0545","article-title":"A novel carbon dots\/thermo-sensitive in situ gel for a composite ocular drug delivery system: characterization, ex-vivo imaging, and in vivo evaluation","volume":"22","author":"Wang","year":"2021","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.nano.2025.102845_bb0550","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/S0378-5173(98)00006-4","article-title":"Lipophilic drug derivatives in liposomes","volume":"165","author":"Gulati","year":"1998","journal-title":"Int J Pharm"},{"key":"10.1016\/j.nano.2025.102845_bb0555","first-page":"7","article-title":"What we need to know about liposomes as drug nanocarriers: an updated review","volume":"13","author":"Abbasi","year":"2023","journal-title":"Adv Pharm Bull"},{"key":"10.1016\/j.nano.2025.102845_bb0560","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1208\/s12249-009-9373-4","article-title":"Ciprofloxacin as ocular liposomal hydrogel","volume":"11","author":"Hosny","year":"2010","journal-title":"AAPS PharmSciTech"},{"key":"10.1016\/j.nano.2025.102845_bb0565","article-title":"Liposomes for tumor targeted therapy: a review","volume":"24","author":"Wang","year":"2023","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.nano.2025.102845_bb0570","doi-asserted-by":"crossref","DOI":"10.3389\/fbioe.2021.716184","article-title":"Platelets in wound healing: what happens in space?","volume":"9","author":"Locatelli","year":"2021","journal-title":"Front Bioeng Biotechnol"},{"key":"10.1016\/j.nano.2025.102845_bb0575","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.molmed.2013.12.001","article-title":"Nanomedicine-based strategies for treatment of atherosclerosis","volume":"20","author":"Schiener","year":"2014","journal-title":"Trends Mol Med"},{"key":"10.1016\/j.nano.2025.102845_bb0580","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1385\/1-59259-175-2:145","article-title":"Therapeutic uses of antioxidant liposomes","volume":"199","author":"Stone","year":"2002","journal-title":"Liposome Methods and Protocols"},{"key":"10.1016\/j.nano.2025.102845_bb0585","doi-asserted-by":"crossref","DOI":"10.1155\/2013\/732340","article-title":"Dendrimeric systems and their applications in ocular drug delivery","volume":"2013","author":"Yavuz","year":"2013","journal-title":"Scientific World Journal"},{"key":"10.1016\/j.nano.2025.102845_bb0590","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/s13036-022-00298-5","article-title":"Dendrimer-based drug delivery systems: history, challenges, and latest developments","volume":"16","author":"Wang","year":"2022","journal-title":"J Biol Eng"},{"key":"10.1016\/j.nano.2025.102845_bb0595","doi-asserted-by":"crossref","first-page":"8036","DOI":"10.1167\/iovs.12-10743","article-title":"Effects of gold nanoparticles on endotoxin-induced uveitis in rats","volume":"53","author":"Pereira","year":"2012","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.nano.2025.102845_bb0600","doi-asserted-by":"crossref","DOI":"10.1002\/advs.202304294","article-title":"Nanomedicine for diagnosis and treatment of atherosclerosis","volume":"10","author":"Cheng","year":"2023","journal-title":"Adv Sci"},{"key":"10.1016\/j.nano.2025.102845_bb0605","doi-asserted-by":"crossref","first-page":"4982","DOI":"10.1167\/iovs.13-12047","article-title":"Topical silver nanoparticles result in improved bleb function by increasing filtration and reducing fibrosis in a rabbit model of filtration surgery","volume":"54","author":"Butler","year":"2013","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.nano.2025.102845_bb0610","doi-asserted-by":"crossref","DOI":"10.3389\/fmolb.2022.931759","article-title":"Nanoparticles in ocular applications and their potential toxicity","volume":"9","author":"Yang","year":"2022","journal-title":"Front Mol Biosci"},{"key":"10.1016\/j.nano.2025.102845_bb0615","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.nano.2018.11.002","article-title":"Nanofluidic microsystem for sustained intraocular delivery of therapeutics","volume":"16","author":"Di Trani","year":"2019","journal-title":"Nanomedicine"},{"key":"10.1016\/j.nano.2025.102845_bb0620","series-title":"Nanomedicine","isbn-type":"print","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/978-981-13-9374-7_32-1","article-title":"Nanomedicine for ocular drug delivery","author":"Xu","year":"2022","ISBN":"https:\/\/id.crossref.org\/isbn\/9789811393747"},{"key":"10.1016\/j.nano.2025.102845_bb0625","doi-asserted-by":"crossref","DOI":"10.1002\/jbm.a.37839","article-title":"Albumin\/hyaluronic acid nanoparticle-laden contact lenses for the ocular delivery of 5-fluorouracil","volume":"113","author":"Senra","year":"2025","journal-title":"J Biomed Mater Res A"},{"key":"10.1016\/j.nano.2025.102845_bb0630","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1021\/acs.biomac.5b01387","article-title":"Preparation and evaluation of contact lenses embedded with polycaprolactone-based nanoparticles for ocular drug delivery","volume":"17","author":"Nasr","year":"2016","journal-title":"Biomacromolecules"},{"key":"10.1016\/j.nano.2025.102845_bb0635","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1016\/j.actbio.2021.04.014","article-title":"Contact lenses coated with hybrid multifunctional ternary nanocoatings (Phytomolecule-coated ZnO nanoparticles:gallic acid:tobramycin) for the treatment of bacterial and fungal keratitis","volume":"128","author":"Khan","year":"2021","journal-title":"Acta Biomater"},{"key":"10.1016\/j.nano.2025.102845_bb0640","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1016\/j.jconrel.2024.10.015","article-title":"Ag\/Cu nanoparticles-loaded glycocalyx biomimetic corneal bandage lenses for combatting bacterial keratitis","volume":"376","author":"Dai","year":"2024","journal-title":"J Control Release"},{"key":"10.1016\/j.nano.2025.102845_bb0645","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2023.123048","article-title":"Contact lenses that transform gold into nanoparticles for prophylaxis of light-related events and photothermal therapy","volume":"641","author":"Alvarez-Lorenzo","year":"2023","journal-title":"Int J Pharm"},{"key":"10.1016\/j.nano.2025.102845_bb0650","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2023.123009","article-title":"Modeling of chitosan modified PLGA atorvastatin-curcumin conjugate (AT-CU) nanoparticles, overcoming the barriers associated with PLGA: an approach for better management of atherosclerosis","volume":"640","author":"Dash","year":"2023","journal-title":"Int J Pharm"},{"key":"10.1016\/j.nano.2025.102845_bb0655","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines8110466","article-title":"Polymeric inserts containing Eudragit\u00ae L100 nanoparticle for improved ocular delivery of azithromycin","volume":"8","author":"Taghe","year":"2020","journal-title":"Biomedicines"},{"key":"10.1016\/j.nano.2025.102845_bb0660","doi-asserted-by":"crossref","DOI":"10.1016\/j.dyepig.2022.110784","article-title":"Carbon quantum dots as ROS-generator and -scavenger: a comprehensive review","volume":"208","author":"Li","year":"2023","journal-title":"Dyes and Pigments"},{"key":"10.1016\/j.nano.2025.102845_bb0665","doi-asserted-by":"crossref","first-page":"141","DOI":"10.2147\/DDDT.S287721","article-title":"Preparation and characterization of tacrolimus-loaded SLNs in situ gel for ocular drug delivery for the treatment of immune conjunctivitis","volume":"15","author":"Sun","year":"2021","journal-title":"DDDT"},{"key":"10.1016\/j.nano.2025.102845_bb0670","doi-asserted-by":"crossref","first-page":"1","DOI":"10.35333\/jrp.2021.292","article-title":"Preparation and in vitro evaluation of tacrolimus loaded liposomal vesicles by two methods: a comparative study","volume":"25","author":"Awasthi","year":"2021","journal-title":"JRP"},{"key":"10.1016\/j.nano.2025.102845_bb0675","doi-asserted-by":"crossref","first-page":"139","DOI":"10.4103\/0975-7406.130965","article-title":"Dendrimers in drug delivery and targeting: drug-dendrimer interactions and toxicity issues","volume":"6","author":"Madaan","year":"2014","journal-title":"J Pharm Bioallied Sci"},{"key":"10.1016\/j.nano.2025.102845_bb0680","doi-asserted-by":"crossref","first-page":"2325","DOI":"10.1128\/AEM.02149-10","article-title":"Antibacterial activity and mechanism of action of zinc oxide nanoparticles against Campylobacter jejuni","volume":"77","author":"Xie","year":"2011","journal-title":"Appl Environ Microbiol"},{"key":"10.1016\/j.nano.2025.102845_bb0685","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1080\/08927014.2013.794225","article-title":"Anti-biofilm activity of silver nanoparticles against different microorganisms","volume":"29","author":"Martinez-Gutierrez","year":"2013","journal-title":"Biofouling"},{"key":"10.1016\/j.nano.2025.102845_bb0690","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.ijbiomac.2014.03.016","article-title":"Preparation, physical\u2013chemical and biological characterization of chitosan nanoparticles loaded with lysozyme","volume":"67","author":"Piras","year":"2014","journal-title":"Int J Biol Macromol"},{"key":"10.1016\/j.nano.2025.102845_bb0695","doi-asserted-by":"crossref","DOI":"10.1038\/srep39272","article-title":"Thiol-capped gold nanoparticles swell-encapsulated into polyurethane as powerful antibacterial surfaces under dark and light conditions","volume":"6","author":"Macdonald","year":"2016","journal-title":"Sci Rep"}],"container-title":["Nanomedicine: Nanotechnology, Biology and Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1549963425000462?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1549963425000462?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,8,18]],"date-time":"2025-08-18T05:57:42Z","timestamp":1755496662000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1549963425000462"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8]]},"references-count":138,"alternative-id":["S1549963425000462"],"URL":"https:\/\/doi.org\/10.1016\/j.nano.2025.102845","relation":{},"ISSN":["1549-9634"],"issn-type":[{"value":"1549-9634","type":"print"}],"subject":[],"published":{"date-parts":[[2025,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Advanced ocular drug delivery in microgravity: Nanotherapeutic applications as cardiovascular and ophthalmic countermeasures","name":"articletitle","label":"Article Title"},{"value":"Nanomedicine: Nanotechnology, Biology and Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.nano.2025.102845","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"102845"}}